Category: Class Action Lawsuit

A Green Vision: Propelling The Environmental CrusadeEconomic growth has become the crux of our society and the has become one of the major fundamental to measure growth. Industrial growth and technological advancement has definitely boosted the world’s economy but depleted

The US Food and Drug Administration (FDA) today reclassified surgical mesh for trans-vaginal repair of pelvic organ prolapse (POP) from a moderate-risk device (class ll) to a high-risk one (class lll) and gave manufacturers 30 months to prove that their

A Delaware court has reduced a recent 100 million (25 million compensatory damages and 75 million punitive damages) verdict against Boston Scientific relating to its class action lawsuit with their trans-vaginal mesh product to 10 million (2.5 million in compensatory

The law firm of Zeb Law, LLP is actively pursuing all nation-wide lawsuits against the manufacturer of the drug Invokana.  We'd like to hear your stories and give you our options.  We can be reached at 800-634-1808.  Please call us.

Takeda, Lilly Lose Bid to Overturn $9 Billion Actos Award - Judge Will Not Overturn Actos Verdict, Takeda Still Owes $9 Billion Takeda Pharmaceutical Co. and Eli Lilly& Co. lost a bid to have a judge throw out a combined

United States Judicial Panel on Multi District Litigation established MDL No. 2545: In re: Testosterone Replacement Therapy Products Liability Litigation. The United States District Court for the Northern District of Illinois will act as the transferee court. The Panel assigned

Johnson & Johnson (JNJ) was ordered by a Texas jury to pay $1.2 million to a woman who alleged one of the company’s lines of vaginal-mesh implants to treat incontinence was defectively designed, in the first verdict against the company

Endo International PLC, announced that it has reached agreements in principle with several leading Plaintiffs' law firms to resolve approximately 20,000 claims relating to vaginal mesh products sold by Endo's an AMS (American Medical Systems), subsidiary. The agreements, which are

A Louisiana federal jury on Monday, April 7, 2014 ordered Takeda Pharmaceutical Co. Ltd. and Eli Lilly & Co. to pay more than $9 billion in damages to a couple, in a bellwether trial over allegations the companies hid the